FT Cboe Vest U.S. Equity Deep Buffer ETF - March DMAR 深 滬
已收盤 12-12 16:00:00 美东时间
41.3949
-0.035
-0.08%
華盛通- 最 高41.41
- 今 開41.34
- 成交量 1.85万股
- 最 低 41.34
- 昨 收 41.43
- 總市值 3.90亿
- 52周最高 41.4682
- 市盈率 靜 --
- 換手率 0.20%
- 52周最低 35.0694
- 委 比 0.00%
- 總股本 942.50万
- 歷史最高 41.4682
- 量 比 1.67
- 振 幅 0.17%
- 歷史最低 29.15
- 每 手 1
- 風險率 1.33%
個股概要
財務分析
公司資料
相關新聞
分紅派息
- 分時圖
- 日k
- 周k
- 月k
相關新聞
更多Fennec Pharmaceuticals Released Topline Results From Phase 2/3 STS-J01 Trial Of Pedmark (Sodium Thiosulfate Injection) For The Reduction Of Cisplatin-induced Ototoxicity In Pediatric And Adolescent And Young Adult Patients With Non-metastatic Solid Tumors In Japan
Study, Which Enrolled 27 Patients, Met Primary Endpoint with a Significant Reduction in Hearing Loss in 3-18 Year Old Patients who Received PEDMARK when Compared with Historically Reported Rates of Hearing Loss in
12-02 20:05
Fennec Pharmaceuticals Reports Increased PEDMARK Sales
Fennec Pharmaceuticals ( ($FENC) ) has released its Q3 earnings. Here is a brea...
11-18 11:53
百时美施贵宝公布两项最新研究数据：氘可来昔替尼可有效治疗银屑病关节炎及系统性红斑狼疮
近日，百时美施贵宝公布了关键性III期POETYK PsA-1 试验的最新数据，进一步证实了氘可来昔替尼在未接受过生物制剂类改善病情抗风湿药物（bDMARD）治...
10-29 16:53
Bristol Myers Squibb's Sotyktu Shows Sustained Efficacy And Safety At Week 52 In POETYK Psa-1 Trial
New data from the pivotal Phase 3 POETYK PsA-1 trial demonstrated that Sotyktu improved and maintained meaningful clinical responses, inhibition of radiographic progression and patient-reported outcomes through Week 52
10-27 19:01
Avenue Supermarts Ltd. Reports Revenue Growth and Store Expansion in Q2FY26
Avenue Supermarts Ltd. ( ($IN:DMART) ) has provided an update. Avenue Supermart...
10-11 19:03
Avenue Supermarts Releases H1 FY 2026 Investor Presentation
Avenue Supermarts Ltd. ( ($IN:DMART) ) has provided an update. Avenue Supermart...
10-11 19:03
HSBC Remains a Sell on Avenue Supermarts Ltd. (DMART)
In a report released today, from HSBC maintained a Sell rating on Avenue Superm...
07-14 02:25
Bristol Myers Squibb Announces Phase 3 POETYK PsA-1 Trial Met Primary Endpoint For Sotyktu In Psoriatic Arthritis
Significantly more patients treated with Sotyktu achieved improvements in joint and skin symptoms, measures of disease activity and quality of life at Week 16 in POETYK PsA-1New data from POETYK PsA-2 trial demonstrated
06-11 19:01
英伟达App实测：老黄终于听劝了，然而却依然只能算半成品？
英伟达的驱动管理软件“英伟达App”，终于更新了。 说实话每次看到英伟达的GeForce Experience，都有一种在看10年前软件的感觉，简陋的UI设计和稀烂的登录界面，让人怀疑英伟达是不是丝毫不重视这个软件。
2024-11-15 14:52
